Purpose The aim of this study was to evaluate health-related quality of life (HRQOL) in patients with different body mass indices (BMI, <25 vs ≥25) undergoing radiation treatment for head and neck cancer. Methods HRQOL was examined by the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 and the EORTC QLQ-H&N35, in the beginning and in the end of radiation treatment in 60 patients treated at University Hospital in Northern Norway. Information about nutritional status with weight loss, hemoglobin level (Hb), serum albumin, and a study-specific questionnaire also was filled out in the beginning and in the end of treatment. The patients' general condition, skin, and mucous membranes (CTCAE v.3.0) (grades 1 to 5 with unique clinical descriptions) were documented four times during radiation treatment. Changes in HRQOL were calculated and compared by paired sample t test. Multiple regression analyses were used to examine correlations between baseline BMI and changes in HRQOL, CTCAE v.3.0 toxicity, nutritional status, and information that radiotherapists provided to patients. Results Patients with BMI≥25 had less mucosal changes after 2 weeks of radiation treatment than patients with BMI<25 (p=0.010). Differences regarding feeding tube use (p=0.037) and intake of nutritional supplements before radiation treatment (p=0.001) were also seen. Patients with overweight had more dyspnea (p=0.033) before treatment and more problems with dry mouth (p=0.042) after treatment. During treatment, patients with BMI≥25 had more problems with opening mouth (p=0.034) than patients with BMI<25 and more changes in sexuality (p=0.019). Patients with BMI≥25 received less information about food and drink (p=0.011) in the radiation treatment period than normal weight patients. Conclusions BMI influences HRQOL and toxicity. Additional longitudinal studies should examine whether or not overweight patients persistently experience more problems with dry mouth and opening their mouth. Regardless of BMI, all patients should be informed about nutritional recommendations during treatment.
Introduction
Patients with head and neck cancer are at high risk for malnutrition due to dysphagia from the tumor itself and treatment toxicity. It is estimated that 25-57 % of cancer patients with tumors in the oral cavity or pharynx already have an impaired nutrition status at the time of diagnosis and before beginning treatment [1, 2] .
Radiotherapy (RT) often results in mucositis, xerostomia, dysphagia, hoarseness, nausea, and vomiting [3] . Approximately 30 % of patients experience weight loss and associated morbidity during treatment [4] .
It is a reliable indicator of malnutrition if patients lose more than 5 % of their usual body weight (BW) in 1 month, or 2 % in 1 week [4] . Poor nutrition diminishes the ability of the immune system to function effectively [5] and increases the risk of infections, hospitalization, and treatment interruption, potentially resulting in poor treatment outcomes [6] . Studies found that maintaining adequate nutrition before and during treatment can decrease weight loss, help to avoid dehydration, and lead to better tolerance without treatment interruptions [4, 7] .
Previous studies have shown that quality of life in head and neck cancer patients is lower at diagnosis compared with the general population and becomes worse during and immediately after treatment [8, 9] . Women score lower than men at diagnosis and immediately after treatment [10, 11] and patients >65 years of age score lower in quality of life studies than those under 65 [11] . In addition, tumor size, smoking, alcohol abuse, depression, social network, personality, and marital status can affect the quality of life of head and neck cancer patients [12] [13] [14] [15] [16] [17] .
However, few studies have focused on the effect of body mass index (BMI) on treatment outcomes [18] . The World Health Organization (WHO) defines overweight as body mass index (BMI) 25-29.9 kg/m 2 and obesity as BMI≥30. Obesity is characterized by a number of side effects; among others, obesity reduces quality of life and physical activity [19] .
There are several reasons why quality of life studies in head and neck cancer patients are important. Better understanding of therapeutic healing aspects will help staff to be able to inform patients and thus prepare them for any function changes and symptoms during RT. Better understanding of different health aspects is also essential for preventing and mitigating functional impairment and symptoms. Although much research has been done regarding quality of life, function, and symptoms, there are still areas that are less well explored. It is for example unclear how overweight and obesity can affect the quality of life of patients undergoing RT. Therefore, we conducted a secondary analysis of a prospective study to evaluate whether BMI was associated with quality of life during RT in head and neck cancer patients. The prospective single-arm study was designed to follow head and neck cancer patients during their radiation treatment period with the purpose to document how the patients experienced the radiotherapy period in terms of information needs, side effects, and quality of life. There are four earlier publications regarding primary aspects of this study [20] [21] [22] [23] .
Methods

Study design and patient sample
The study was conducted at the University Hospital in Northern Norway, in the time period from May 2009 to November 2012. All ambulatory adult patients (18 years or older) with an untreated primary head and neck cancer, referred to the oncology center for radiotherapy, were potentially eligible to participate in the study. Exclusion criteria were patients who were unable to answer the health-related quality of life (HRQOL) questionnaires as a result of mental disturbance, or unable to fill in the questionnaire for other reasons, e.g., poor general condition, or if they were unable to speak and understand Norwegian. Totally 87 potentially eligible patients were originally identified. Eligible patients received a letter explaining the purpose and the methods of the study and the level of commitment required to participate. A research assistant met the patients during treatment planning or initiation to seek consent and administer the questionnaire. Eighty-two patients met the criteria and were invited to attend the study. Three patients refused participation and one relative of a patient declined. Eleven patients did not return the written consent. Sixty-seven were included, providing an attendance rate of 82.7 %. Sixty patients had available BMI data. The study was approved by the Regional Committee for Medical Research Ethics (P REK NORD 200900504-3KST017/400) and the Norwegian Social Science Data Services (21831).
Data collection
Sociodemographic and tumor-related patient characteristics were recorded at inclusion, i.e., sex, age, tumor location according to ICD-10, TNM stage (T=tumor size, N=node, M=metastasis), and planned treatment. In addition, a studyspecific questionnaire about which information the health care workers had given the patients was filled out twice by the research radiation therapist, before the patients started treatment and after they completed treatment. The patients responded to what information they had received about nutrition and which food and drinks they should avoid during the radiation treatment period. Information regarding dietary counseling was not structured before or under radiation treatment; the doctors, nurses, and radiation therapists gave individual dietary advice. The patients were provided with verbal nutrition information from the radiation therapists during the treatment. They were not encouraged to use media or websites to gain further information. The nutrition information questionnaire consisted of open questions where the patients should answer the radiation therapist. Patients were also asked about current use of nutritional supplements such as powders or liquids providing extra calories and if they wanted to talk to a nutritionist. In addition, nutritional status with weight loss, hemoglobin level (Hb), and serum albumin was filled out in the beginning (0 Gy), after 2 weeks (20 Gy), after 4 weeks (40 Gy), and after 6 weeks (60 Gy) by the research radiation therapist. The patients' general condition, skin, and mucous membranes (CTCAE v.3.0) (mucositis clinical, grades 1 to 5 with unique clinical descriptions) were documented by the research radiation therapist four times during radiation treatment, in the beginning (0 Gy), after 2 weeks (20 Gy), after 4 weeks (40 Gy), and after 6 weeks (60 Gy).
HRQOL questionnaires
Data were collected at two time points: at baseline which was the first radiation treatment week (T1) and during the last week after 60 Gy (T4). At T1 and T4, the patients filled in the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 [24] and EORTC QLQ-H&N35 [25] . The EORTC QLQ-C30 questionnaire is a generic questionnaire to all cancers. The questionnaire is a patient-based measurement designed for self-administration which assesses multiple dimensions of HRQOL, and responses of this 30-item questionnaire are categorized into five functional domains (physical, role, emotional, cognitive, and social) scored on a four-point scale, one global HRQOL domain (scored on a seven-point scale), three symptom domains (fatigue, nausea/ vomiting, pain), and six single items (scored on a four-point scale). Each score is transformed into 0-100-point scale. Both EORTC instruments were scored according to recommendations in the EORTC QLQ-C30 scoring manual [8] . In the five functional scales and the global HRQOL scale, a high score represents a high level of functioning or global HRQOL. In the symptom scales and single items, a higher score implies a high level of symptoms or problems. EORTC QLQ-H&N35 is a questionnaire specifically developed for head and neck cancer patients consisting of 35 items on health-related HRQOL. It includes seven scales (pain, swallowing, senses, speech, social eating, social contact, and sexuality) and 11 single items (problems with teeth, problems opening the mouth, dry mouth, sticky salvia, cough, feeling ill, pain killers, nutritional supplements, feeding tube, weight loss, and weight gain). Items 1-30 are scored on a four-point scale (1, not at all; 2, a little; 3, quite a bit; 4, very much). Items 31-35 have a yes (2) or no (1) response format. Given that all the scales assess symptoms, higher scores correspond to lower quality of life.
Clinical treatment
Radiotherapy was administered to the primary tumor and the regional neck lymphatics (dependent on N stage) by conventional fractionation, i.e., dose of 2 Gy, one fraction per day, 5 days per week. The total radiation doses were 60-70 Gy. RT was delivered using megavoltage equipment (6-MV linear accelerator) over a period of 6 to 7 weeks. In all patients, thermoplastic mask immobilization and planning computed tomography scans were used, and all patients were treated with three-dimensional conformal (n = 48) or intensitymodulated radiotherapy (n=12). None of the patients had distant metastases. The patients received standardized oral care kits before radiotherapy, which contained soft toothbrush, flourished toothpaste without soap, artificial salvia spray and lozenges, fluoride mouthwash, saltwater, and dexpanthenol lotion. Further counseling was individualized.
Statistical analysis
In the present study, the primary outcome of interest was to examine correlations between obesity and quality of life during RT. Secondary outcomes were differences in information that obese patients received compared to normal weight patients regarding nutrition. Sixty patients with available BMI data were included. Changes in HRQOL were calculated and compared by paired sample t test. Multiple regression analyses were used to examine correlations between baseline BMI and changes in HRQOL, CTCAE v.3.0 toxicity, nutritional status, and information that radiotherapists provided to patients. To obtain the latter parameter, patients' answers were converted to a threetiered score, which was compared between groups by Pearson chi-square test. Baseline frequency data were compared by Fisher exact probability test. The significance level was set at p=0.05 using the statistical software SPSS 19.0 for Windows.
Results
Mean age of all 60 patients was 60 years. Seventy-seven percent were males (Table 1) . Twenty-five percent were never smokers. Mean BMI was 25.7 (<25 in 26 patients, 43 %). There were nine obese (BMI>30) patients, and one underweight (BMI<18.5) patient. The differences in baseline parameters included in Table 1 (for example chemotherapy utilization, baseline weight loss, or gender) between overweight and normal weight patients were not statistically significant. There was no statistically significant difference in baseline Hb and serum albumin between overweight and normal weight patients either ( Table 2) . As also shown in Table 2 , BMI decreased slightly during radiotherapy, both in overweight and normal weight patients. Numerical decreases in Hb and albumin were also found. The magnitude of these changes was similar in both groups. Table 3 shows that quality of life (EORTC QLQ-C30) was largely comparable at baseline, except for dyspnea which was significantly worse in overweight patients. Differences between baseline and end of treatment were similar in both groups. Table 4 shows the results of the QLQ-H&N35 questionnaire. At baseline, overweight patients had lower rates of feeding tube use (p=0.037) and intake of nutritional supplements (p=0.001). At the end of treatment, overweight patients had significantly more problems with dry mouth (p=0.042). During treatment, patients with BMI≥25 had more problems with opening mouth (p=0.034) than patients with BMI<25 and more changes in sexuality (p=0.019). The persistent differences in feeding tube use lie below the border of statistical significance. Tables 5 and 6 show that patients with BMI≥25 had less mucosal changes after 2 weeks of radiation treatment than patients with BMI<25 (p=0.010), and comparable trends were seen at later time points. However, this difference was not statistically significant at later time points when the higher cumulative radiation doses generally caused more severe side effects. Course of skin changes and performance status was not clearly related to BMI. Patients with BMI≥25 received less information about food and drinks that they should avoid in the radiation treatment period than normal weight patients (p=0.011), although general nutrition information was comparable between the groups (Table 7) .
Discussion
During initial analyses of the prospective study [20] [21] [22] [23] , the authors developed a hypothesis that patients with normal and low BMI had more nutrition problems and therefore need more tube feeding than patients with overweight. The secondary analyses in the present exploratory study indicate that there were no significant differences, but they also show that BMI affected HRQOL and toxicity during radiation therapy. Head and neck cancer patients with high BMI (≥25) faced several challenges compared to patients with BMI<25 before, during, and after radiation treatment, except from mucosal [26] who showed that higher BMI was associated with worse quality of life (QOL) for breast cancer patients before, during, and after RT. The results are not consistent with those reported by Al-Naggar et al. [27] who examined QOL of breast cancer patients in Yemen and found a difference between underweight and overweight patients for emotional well-being. However, comparisons across both different disease types and cultures are difficult to interpret.
Our study is the first to demonstrate that there is a connection between head and neck cancer patients' BMI, their HRQOL, and the individualized dietary counseling in the treatment period. The data presented here also illustrate that a considerable number of functions and symptoms are similar between the two BMI groups examined during RT for head and neck cancer. Before treatment, overweight patients had more dyspnea than normal weight patients. As might be expected intuitively, lower rates of feeding tube use and lower intake of nutritional supplements were found in this subgroup. In a previous study, Van Bokhorstde van der Schueren et al. [28] evaluated the use of perioperative nutritional support on QOL in 49 malnourished head and neck cancer patients. They found that patients who received preoperative tube-feeding and nutritional supplements experienced dyspnea relief [28] . Høgdal [29] has in a master thesis examined pretreatment HRQOL in 81 patients suffering from head and neck cancer. She found that these patients had more dyspnea before RT than normal population [29] . This finding might be related to the fact that half of these patients are smokers [29] . In Høgdal's thesis [29] , it was not focused on patients' weight or BMI status. Other studies have also reported higher baseline dyspnea scores in head and neck cancer patients [25, 30, 31] . In our study, patients with BMI ≥25 had more dyspnea than patients with BMI<25, in the absence of significant differences in smoking status between the groups (objective measures of lung function were not performed). This result can possibly be explained by links between obesity and chronic diseases such as hypertension, coronary heart disease, and congestive heart failure. Hammerlid et al. [32] evaluated the connection between QOL and nutritional status and energy intake for head and neck cancer patients. They found no significant differences, but the malnourished patients scored worse on 12 of the 16 functional domains/symptoms [32] . Besides dyspnea, we found significant differences between the two groups regarding use of nutritional supplements and feeding tubes at baseline. Tumor location and size might lead to nutritional difficulties before treatment [33, 34] . Some studies have reported an association between poor nutrition and development of mucositis [35] [36] [37] . The potential mechanism of the association between BMI and oral mucositis is uncertain [38] . Oral mucositis is one of the most serious problems connected to head and neck cancer radiotherapy [39, 40] , and severe cases may require feeding tube placement. The data presented here illustrate how oral mucositis develops in the two BMI groups during radiotherapy. At baseline, there were no significant differences between the groups, but after 2 weeks of radiation treatment, patients with BMI≥25 had less mucosal changes than patients with BMI< 25. After this time period, oral mucositis did not differ significantly between the groups. Saito et al. [38] examined whether low BMI could be a risk factor for oral mucositis. In their study, 33 patients with oral cancer received radiotherapy and they found that low BMI (<22) may be a risk factor of moderate to severe oral mucositis. Virtually, all patients who receive radiation therapy for head and neck cancer develop some degree of oral mucositis [39] . The incidence of oral mucositis has been reported to vary in relation to various patient characteristics, including low body mass index, altered oral intake, and poor functional status, but the data supporting these potential non-dosimetric risk factors are inconsistent. At least in part, small group sizes and variations in RT technique and exposed mucosa surface might explain why variable correlations have been observed.
In the present study, a significant correlation was also shown between overweight and problems with opening mouth and less sexuality during radiation treatment. Høgdal [29] found comparable correlations in the same HRQOL domains. Since risk factors for restricted mouth opening in head and neck cancers include tumor location and proximity to relevant muscles [41] , imbalances might confound QOL results, but we found no significant correlation between BMI and location or T stage.
Our patients with BMI≥25 had more problems with dry mouth after RT than patients with BMI<25. This is interesting since there is a possibility that weight loss and contour changes in the neck region could account for accidental increase in dose to the salivary glands. This could explain the finding in the higher BMI group, but the number of patients was small. Kakoei et al. [42] highlighted the relationship between low QOL and dry mouth among patients irradiated for head and neck cancer. Head and neck cancer patients who underwent radiotherapy began to experience xerostomia after start of treatment, and this leads to a decrease in QOL during radiotherapy [42] . Previous studies have demonstrated that xerostomia, which is caused by permanent damage to the salivary glands in the irradiated region, is a common and important complaint among patients who undergo head and neck radiotherapy [43, 44] . According to other studies, the effect of xerostomia on oral health and QOL is very important [42, 45] . In a study conducted in 2006, Pow et al. [44] compared the effect of intensity-modulated radiotherapy (IMRT) vs. conventional radiotherapy on salivary flow and Information about nutrition and food and drinks that should be avoided before and during treatment is presented in bold QOL. They found consistent improvement over time in the IMRT group, with xerostomia-related symptoms significantly less common than in the conventional radiotherapy group [44] . None of these studies have focused on patients' BMI. We found no significant imbalance in IMRT use between the two BMI groups. Possibly, in the absence of adaptive radiotherapy with replanning based on new CT scans, obese patients might experience relatively larger changes in anatomy, which might result in higher than anticipated dose to the salivary glands [46] . During treatment, patients with BMI≥25 received less information about food and drink that should be avoided than normal weight patients. The authors did not compare patient recollection with the actual nutritional advice and information provided, which is a weakness of our study. It is tempting to speculate that identical information policies would have contributed to better QOL and fewer side effects in overweight patients, which had less mucositis despite poorer counseling. However, this hypothesis needs prospective testing. Access to other sources of information including publicly available brochures and websites as well as communication with fellow patients might compensate for imbalances.
The clinical manifestations of radiation injury and its nutritional consequences have been well described [47] . Several studies have shown a relationship between nutrition support, weight gain, and improved QOL [48, 49] . Ravasco et al. [7] performed a prospective randomized controlled trial with 75 patients with head and neck cancer to determine the effect of dietary counseling on outcome and QOL during and 3 months after radiotherapy [7] . They found that during RT, dietary counseling improved all QOL function scores in association with an adequate dietary intake and nutritional status [7] . The results from the present study provide important information about head and neck cancer patients treated with radiotherapy and the association of overweight with HRQOL, comparable to a previous breast cancer study [26] . Implications for practice include the need for health care providers to be aware of the impact that overweight and low weight have on patients' HRQOL. Patients in the low BMI group had already commenced nutritional support with supplements and tube feeding before treatment, and this group continued to need greater nutritional support during treatment. Health care providers should be aware of patients' need for nutritional information and support. A main limitation of our study is the short period of follow-up. Additional longitudinal studies should examine whether or not overweight patients persistently experience more problems with dry mouth and opening their mouth. Another weakness of the present study is the lack of information about patients' compliance with dietary and oral care counseling. Regardless of BMI, all patients should be informed about nutritional recommendations during treatment and receive appropriate follow-up care and rehabilitation for reduced swallowing and mouth opening function.
